<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-08T23:22:33+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>武田抗巨细胞病毒药物phase III研究获得阳性结果</title>
    <updated>2020-12-08T22:15:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/3oqcYZHKalhVOF3wfEFZSA</id>
    <link href="https://mp.weixin.qq.com/s/3oqcYZHKalhVOF3wfEFZSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音｜维布妥昔单抗联合纳武利尤单抗用于高危霍奇金淋巴瘤患者自体造血干细胞移植后巩固治疗</title>
    <updated>2020-12-08T22:15:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/cOrjFEDc9wKqDIx4bL2atQ</id>
    <link href="https://mp.weixin.qq.com/s/cOrjFEDc9wKqDIx4bL2atQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH好声音 | 傅卫军教授解读：TOURMALINE-MM4研究中伊沙佐米维持治疗对于不同MRD状态的NDMM患者的PFS获益</title>
    <updated>2020-12-08T22:15:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/iv2hFYn8bm92ZyHWoS754g</id>
    <link href="https://mp.weixin.qq.com/s/iv2hFYn8bm92ZyHWoS754g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以患者为中心说到不如做到</title>
    <updated>2020-12-07T19:30:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/88BAB8QrPZkZr9KTmToKDQ</id>
    <link href="https://mp.weixin.qq.com/s/88BAB8QrPZkZr9KTmToKDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH好声音 |【朱军教授点评】 ECHELON-1研究5年结果更新：BV联合化疗用于 III/IV期cHL患者的一线治疗</title>
    <updated>2020-12-07T19:30:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/wH6HM1-FFXns_y3cU0KHGg</id>
    <link href="https://mp.weixin.qq.com/s/wH6HM1-FFXns_y3cU0KHGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音｜MRD检测在多发性骨髓瘤中的应用进展</title>
    <updated>2020-12-07T19:30:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/xakNI7w7R7cwyHOwO1ILJw</id>
    <link href="https://mp.weixin.qq.com/s/xakNI7w7R7cwyHOwO1ILJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EGFR/HER2靶向药来那替尼（Niratinib）中文说明书</title>
    <updated>2020-12-07T19:30:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/VPdn-4jURwX_HJ1TLTb7uQ</id>
    <link href="https://mp.weixin.qq.com/s/VPdn-4jURwX_HJ1TLTb7uQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华为涉足医药界</title>
    <updated>2020-12-06T21:15:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/wBdQkbohRJYZ2NuMMDYTKA</id>
    <link href="https://mp.weixin.qq.com/s/wBdQkbohRJYZ2NuMMDYTKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 熟悉的身影、全新的舞台：口服蛋白酶体抑制剂的新玩法</title>
    <updated>2020-12-06T21:15:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/dJytPLsB607qnGwKbLGuSg</id>
    <link href="https://mp.weixin.qq.com/s/dJytPLsB607qnGwKbLGuSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音|陈文明教授：PI同类药物转换支持非移植骨髓瘤的持续治疗</title>
    <updated>2020-12-06T21:15:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/4lFjicltd-831yRzvBD6-A</id>
    <link href="https://mp.weixin.qq.com/s/4lFjicltd-831yRzvBD6-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传性血管性水肿（HAE）大合集</title>
    <updated>2020-12-05T10:27:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/nNlPQVZxbbcbNXbFQizikg</id>
    <link href="https://mp.weixin.qq.com/s/nNlPQVZxbbcbNXbFQizikg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 复发难治多发性骨髓瘤最新研究详述（二）</title>
    <updated>2020-12-05T10:27:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/AHVzfpcM31Zo5TY_vKsk0A</id>
    <link href="https://mp.weixin.qq.com/s/AHVzfpcM31Zo5TY_vKsk0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | B细胞淋巴瘤最新研究</title>
    <updated>2020-12-05T10:27:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/BSCTMFL4C4P_DvcDz6mYLg</id>
    <link href="https://mp.weixin.qq.com/s/BSCTMFL4C4P_DvcDz6mYLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田制药荣获天津市先进外商投资企业称号</title>
    <updated>2020-12-04T17:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/oXUGvkjc0UCiFVhooT3upA</id>
    <link href="https://mp.weixin.qq.com/s/oXUGvkjc0UCiFVhooT3upA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 来自邱录贵教授团队——多发性骨髓瘤中国研究专题</title>
    <updated>2020-12-04T17:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yzl-Vg8HYt0qQtJnfV7MXA</id>
    <link href="https://mp.weixin.qq.com/s/yzl-Vg8HYt0qQtJnfV7MXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 陈锐教授：FVIII药代动力学计算工具助力血友病个体化治疗</title>
    <updated>2020-12-03T18:12:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/9-WgGGHKO19l2hVxVRkKWQ</id>
    <link href="https://mp.weixin.qq.com/s/9-WgGGHKO19l2hVxVRkKWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>J-ALTA二期临床结果（阿来替尼→布格替尼）</title>
    <updated>2020-12-02T20:52:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/ES4sDlFKF-XVPDG1JYUTCQ</id>
    <link href="https://mp.weixin.qq.com/s/ES4sDlFKF-XVPDG1JYUTCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服剂型:Relugolix用于晚期前列腺癌的雄激素剥夺治疗</title>
    <updated>2020-12-01T19:10:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/q-60I8Ne49VZ9sa0QAiy2Q</id>
    <link href="https://mp.weixin.qq.com/s/q-60I8Ne49VZ9sa0QAiy2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 蔡真教授：多发性骨髓瘤患者的维持治疗</title>
    <updated>2020-12-01T19:10:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/3X-sT7fPp2FU_XSgTTLw0Q</id>
    <link href="https://mp.weixin.qq.com/s/3X-sT7fPp2FU_XSgTTLw0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纳武利尤单抗联合化放疗治疗不可手术的III期NSCLC</title>
    <updated>2020-11-30T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/K2pfUn8xkpH1N-RoNV601w</id>
    <link href="https://mp.weixin.qq.com/s/K2pfUn8xkpH1N-RoNV601w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>